Search

Your search keyword '"Hungerford, Daniel"' showing total 284 results

Search Constraints

Start Over You searched for: Author "Hungerford, Daniel" Remove constraint Author: "Hungerford, Daniel"
284 results on '"Hungerford, Daniel"'

Search Results

2. Genomic insights into the 2022–2023Vibrio cholerae outbreak in Malawi

7. Measuring the effect of rotavirus vaccination in primary and secondary care in Merseyside, UK

8. Linking epidemiological and genomic data in cases of enteric fever in England to inform clinical management and public health action.

19. Draft genomes of Aeromonas caviae from patients with cholera-like illness during the 2022–2023 cholera outbreak in Malawi

31. Screening and Brief Intervention for Alcohol Problems among College Students Treated in a University Hospital Emergency Department

33. Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: A cohort analysis of 2.7M people

34. Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines

35. Additional file 1 of Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2

36. Additional file 1 of Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: a cohort analysis of 2.7 M people

38. Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK

39. Reduction in Severity of All-Cause Gastroenteritis Requiring Hospitalisation in Children Vaccinated against Rotavirus in Malawi

43. Socioeconomic and ethnic inequalities in incidence and severity of enteric fever in England 2015–2019: analysis of a national enhanced surveillance system.

44. Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2

Catalog

Books, media, physical & digital resources